CORT Corcept Therapeutics Incorporated

63.62USD-2.09%Mkt Cap: 6.96B USDP/E: 47.83

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.…